The SELECT cardiovascular outcomes trial published in 2023 added a cardiovascular benefit signal: semaglutide reduced major adverse cardiovascular events by 20% in overweight and obese patients with established cardiovascular disease, independent of diabetes status
Barre A, Gusto G, Cadeau C, Carbonnel F, Boutron-Ruault MC
For patients in this situation, abdominoplasty, commonly called a tummy tuck, may offer a solution
Be Cautious With Effective at a Lower Dose A formulation may produce higher blood exposure in a pharmacokinetic study, but that does not automatically establish that a lower dose produces the same clinical result
Early research shows that taking L-carnitine daily can reduce total cholesterol, low-density lipoprotein (LDL or "bad") cholesterol, and triglycerides in children with high blood fat levels